Monday - November 17, 2025
DEA Issues Notice of Application From SpecGx LLC for Bulk Manufacturing of Schedule I and II Controlled Substances
April 25, 2025
WASHINGTON, April 25 (TNSFR) -- The U.S. Department of Justice Drug Enforcement Administration has issued a formal notice of application from SpecGx LLC seeking registration as a bulk manufacturer of numerous Schedule I and Schedule II controlled substances. The Saint Louis, Missouri-based company submitted its application on February 17, 2025, to manufacture a wide range of substances for use in pharmaceutical ingredient production and scientific research.

The application lists ove . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products